Cargando…

IL-18 blockade is a potential disease-modifying therapy for rheumatoid arthritis

Detalles Bibliográficos
Autores principales:	Plater-Zyberk, C, Joosten, LAB, Helsen, MMA, Sattonnet-Roche, P, Siegfried, C, Alouani, S, van de Loo, FAJ, Graber, P, Aloni, S, Dinarello, CA, van den Berg, WB, Chvatchko, Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273251/ http://dx.doi.org/10.1186/ar261

Ejemplares similares

Local interleukin-12 gene transfer promotes conversion of an acute to a chronic destructive murine streptococcal cell wall arthritis
por: Joosten, LAB, et al.
Publicado: (2001)

IL-18 directly promotes joint inflammation and induces cartilage destruction through IL-1
por: Joosten, L, et al.
Publicado: (2003)

Local IL-18 gene transfer prevents severe joint destruction in murine collagen-induced arthritis by induction of IL-4 and osteoprotegerin
por: Joosten, LAB, et al.
Publicado: (2005)

The effects of interferon-β (IFN-β) treatment on synovial cytokine expression in collagen induced arthritis in DBA/1 mice
por: van Holten, J, et al.
Publicado: (2002)

Reporter cell lines for real-time imaging of NF-κB activation in the arthritic joint
por: Smeets, RL, et al.
Publicado: (2004)

Suppressor of cytokine signaling (SOCS)-3 gene transfer protects against collagen-induced arthritis
por: van de Loo, FAJ, et al.
Publicado: (2004)

Endogenous IL-12p40 is crucial for antigen-induced arthritis and is partly involved in chronic relapsing streptococcal-cell-wall arthritis
por: Jacobs, M, et al.
Publicado: (2003)

Interleukin-1 receptor antagonist lentiviral gene transfer to the murine knee joint ameliorates collagen-induced arthritis
por: van de Loo, FAJ, et al.
Publicado: (2005)

IFN-β for the treatment of rheumatoid arthritis?
por: Tak, P, et al.
Publicado: (2003)

IL-1-driven cartilage and bone destruction are dependent on Toll-like receptor (TLR) 4, but not TLR2
por: Abdollahi-Roodsaz, S, et al.
Publicado: (2005)

inflammation-inducible intra-articular production of human IL-1 receptor antagonist results in a more efficient inhibition of collagen-induced arthritis than does constitutive expression of the same transgene
por: Bakker, AC, et al.
Publicado: (2001)

Interferon-β for treatment of rheumatoid arthritis?
por: van Holten, Judith, et al.
Publicado: (2002)

Genome-wide gene expression in experimental arthritis: defining new targets of chronic/destructive rheumatoid arthritis (RA)
por: Takahashi, N, et al.
Publicado: (2002)

Using a tropism-modified adenoviral vector for the intra-articular production of IL-1 receptor antagonist results in a more efficient inhibition of collagen-induced arthritis than does a conventional Ad5 vector
por: Bakker, AC, et al.
Publicado: (2001)

Intracellular expression of CXCR3 on rheumatoid arthritis synovial tissue cells
por: Krystufkova, O, et al.
Publicado: (2001)

Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis
por: van Holten, Judith, et al.
Publicado: (2004)

Citrullination of synovial proteins in murine models of rheumatoid arthritis
por: Vossenaar, E, et al.
Publicado: (2003)

Identification of a natural soluble form of the IL-18 receptor accessory protein as an immunomodulator in experimental arthritis
por: Smeets, RL, et al.
Publicado: (2005)

Adenoviral transfer of murine OncostatinM induces inflammation and bone apposition in joints of IL-1, IL-6 and TNF-α deficient mice
por: de Hooge, ASK, et al.
Publicado: (2002)

Local inhibition of endogenous IL-18 through adenoviral overexpression of IL-18BPc results in reduced incidence and severity of collagen induced arthritis in mice
por: Smeets, RL, et al.
Publicado: (2002)

Toll-like receptor 4 polymorphism influences susceptibility to but not severity and outcome of rheumatoid arthritis
por: Radstake, TRDJ, et al.
Publicado: (2004)

IL-18 expression in synovial biopsies of patients with active rheumatoid arthritis is associated with enhanced levels of both IL-1 and TNFα
por: Joosten, LAB, et al.
Publicado: (2002)

Expression of Toll-like receptor (TLR) 2, TLR3, TLR4 and TLR7 is increased in rheumatoid arthritis synovium and regulates cytokine production by dendritic cells upon stimulation of TLR specific pathways
por: Roelofs, MF, et al.
Publicado: (2005)

Neutralizing IL-17 during re-activation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and IL-1
por: Koenders, MI, et al.
Publicado: (2005)

Effects of overexpression of PAD4 enzyme in mouse synovium
por: Zendman, AJW, et al.
Publicado: (2005)

IL-1-dependent cartilage damage in a macrophage-driven arthritis model can be circumvented by T cell IL-17
por: Koenders, MI, et al.
Publicado: (2004)

Local IL-17 gene therapy accelerates collagen arthritis with severe bone erosion and rank ligand and rank expression in synovial infiltrate and at bone erosion sites
por: Lubberts, E, et al.
Publicado: (2001)

Why not treat human cancer with interleukin-1 blockade?
por: Dinarello, Charles A.
Publicado: (2010)

Increased FcγRII and III expression in synovium and on monocyte derived macrophages of RA-patients results in altered function after immune complex stimulation
por: Blom, AB, et al.
Publicado: (2002)

Built Environment and Physical Functioning in Hispanic Elders: The Role of “Eyes on the Street”
por: Brown, Scott C., et al.
Publicado: (2008)

A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock
por: Chvatchko, Yolande, et al.
Publicado: (2000)

Neutralizing synovial RANKL by local OPG gene therapy in collagen-induced arthritis prevents cartilage erosion through induction of a non-destructive type 2 synovitis
por: Lubberts, E, et al.
Publicado: (2004)

Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis
por: van Nieuwenhuijze, Annemarie E. M., et al.
Publicado: (2015)

TNF-α dependency of IL-17-induced joint pathology differs under naive and arthritis conditions in vivo
por: Koenders, M, et al.
Publicado: (2003)

Health Disparities in the Relationship of Neighborhood Greenness to Mental Health Outcomes in 249,405 U.S. Medicare Beneficiaries
por: Brown, Scott C., et al.
Publicado: (2018)

Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure
por: Cavalli, Giulio, et al.
Publicado: (2017)

Efficient IL-18 and IL-18BPc adenoviral gene transfer to cultured murine submandibular gland epithelial cells and successful murine retrograde submandibular duct cannulation to modulate IL-18 function in the salivary gland of animal models of Sjogren's syndrome
por: Bombardieri, M, et al.
Publicado: (2005)

Immunocytokines: the long awaited therapeutic magic bullet in rheumatoid arthritis?
por: van de Loo, Fons A, et al.
Publicado: (2009)

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
por: Joosten, Leo AB, et al.
Publicado: (1999)

Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract
por: Essaidi-Laziosi, Manel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t5aean0b6pg6aselqb778mt6p9